慢性自发性荨麻疹患者自体血清皮肤试验的免疫学机制及与临床特征和预后的关系

doi:10.35541/cjd.20210377

中华皮肤科杂志 ›› 2023, Vol. 56 ›› Issue (2): 184-187.doi: 10.35541/cjd.20210377

• 综述 • 上一篇

慢性自发性荨麻疹患者自体血清皮肤试验的免疫学机制及与临床特征和预后的关系

于淼^1，2 宋晓婷¹ 刘擘¹ 廖双璐¹ 栾婷婷^1，2 赵作涛¹

¹北京大学第一医院皮肤科北京市皮肤病分子诊断重点实验室国家皮肤与免疫疾病临床医学研究中心，北京 100034；²北京大学护理学院，北京 100191

收稿日期:2021-05-12 修回日期:2021-12-25 发布日期:2023-02-01
通讯作者: 赵作涛 E-mail:zhaozuotaotao@163.com

Autologous serum skin test: immunological mechanisms and its associations with clinical features and prognosis of chronic spontaneous urticaria

Yu Miao^1,2, Song Xiaoting¹, Liu Bo¹, Liao Shuanglu¹, Luan Tingting^1,2, Zhao Zuotao¹

¹Department of Dermatology, Peking University First Hospital, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, National Clinical Research Center for Skin and Immune Diseases, Beijing 100034, China; ²Peking University School of Nursing, Beijing 100191, China

Received:2021-05-12 Revised:2021-12-25 Published:2023-02-01
Contact: Zhao Zuotao E-mail:zhaozuotaotao@163.com

摘要/Abstract

摘要： 【摘要】自体血清皮肤试验（ASST）在临床上常用于筛查慢性自发性荨麻疹（CSU）的免疫亚型，但其免疫学机制、与CSU患者临床特征及预后的关系尚未明确。研究显示，ASST阳性与CSU患者免疫球蛋白G自身抗体升高、嗜酸性粒细胞和嗜碱性粒细胞计数减少、嗜碱性粒细胞CD63表达升高、循环炎症细胞因子水平变化相关，与患者年龄、病程以及个人或家族史无关，但可能是慢性荨麻疹病情严重程度的预测指标。ASST阳性患者可能对第二代H1抗组胺药反应不佳，对奥马珠单抗起效缓慢，但对环孢素和自体全血/血清注射治疗反应良好。该文综述ASST阳性患者的免疫学和临床特征，探讨ASST阳性对不同治疗方案疗效的预测作用。

关键词: 荨麻疹, 慢性自发性荨麻疹, 自体血清皮肤试验, 免疫球蛋白G, 奥马珠单抗

Abstract: 【Abstract】 Autologous serum skin test （ASST） is commonly used as a screening test to assess immune subtypes of chronic spontaneous urticaria （CSU） in clinical practice, but its immunological mechanisms and associations with clinical features and prognosis of CSU are not yet clear. Studies have shown that positive ASST is associated with increased immunoglobulin G autoantibodies, decreased eosinophil and basophil counts, increased CD63 expression on basophils, and changes in circulating inflammatory cytokine levels in CSU patients, but not associated with age, disease duration, and personal or family history of CSU patients, and may be a predictor of severity of chronic urticaria. ASST-positive patients may respond poorly to second-generation H1 antihistamines, slowly to omalizumab, but respond well to cyclosporine and autologous whole blood/serum injections. This review summarizes the immunological and clinical characteristics of ASST-positive patients, and discusses the predictive value of positive ASST for the efficacy of different treatment regimens.

Key words: Urticaria, Chronic spontaneous urticaria, Autologous serum skin test, Immunoglobulin G, Omalizumab

于淼宋晓婷刘擘廖双璐栾婷婷赵作涛. 慢性自发性荨麻疹患者自体血清皮肤试验的免疫学机制及与临床特征和预后的关系[J]. 中华皮肤科杂志, 2023,56(2):184-187. doi:10.35541/cjd.20210377

Yu Miao, Song Xiaoting, Liu Bo, Liao Shuanglu, Luan Tingting, Zhao Zuotao. Autologous serum skin test: immunological mechanisms and its associations with clinical features and prognosis of chronic spontaneous urticaria[J]. Chinese Journal of Dermatology, 2023, 56(2): 184-187.doi:10.35541/cjd.20210377

参考文献 28

［1］	中华医学会皮肤性病学分会荨麻疹研究中心. 中国荨麻疹诊疗指南（2018版）［J］. 中华皮肤科杂志, 2019,52（1）:1⁃5. doi: 10.3760/cma.j.issn.0412⁃4030.2019.01.001.
［2］	Bracken SJ, Abraham S, MacLeod AS. Autoimmune theories of chronic spontaneous urticaria［J］. Front Immunol, 2019,10:627. doi: 10.3389/fimmu.2019.00627.
［3］	Altrichter S, Zampeli V, Ellrich A, et al. IgM and IgA in addition to IgG autoantibodies against FcɛRIα are frequent and associated with disease markers of chronic spontaneous urticaria［J］. Allergy, 2020,75（12）:3208⁃3215. doi: 10.1111/all.14412.
［4］	Konstantinou GN, Asero R, Ferrer M, et al. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria［J］. Allergy, 2013,68（1）:27⁃36. doi: 10.1111/all.12056.
［5］	Asero R, Pinter E, Tedeschi A. 35 years of autologous serum skin test in chronic spontaneous urticaria: what we know and what we do not know［J］. Eur Ann Allergy Clin Immunol, 2021. doi: 10.23822/EurAnnACI.1764⁃1489.238.
［6］	Konstantinou GN, Asero R, Maurer M, et al. EAACI/GA（2）LEN task force consensus report: the autologous serum skin test in urticaria［J］. Allergy, 2009,64（9）:1256⁃1268. doi: 10.1111/j. 1398⁃9995.2009.02132.x.
［7］	柯娅楠, 杨坤霞, 余泳, 等. 慢性荨麻疹患者自体血清皮肤试验结果判读时间的探讨［J］. 皮肤性病诊疗学杂志, 2018,25（2）:88⁃89,100. doi: 10.3969/j.issn.1674⁃8468.2018.02.008.
［8］	冯林, 宋志强, 郝飞. 自体血清皮肤试验在慢性荨麻疹的应用进展［J］. 临床皮肤科杂志, 2011,40（8）:508⁃510. doi: 10.3969/j.issn.1000⁃4963.2011.08.030.
［9］	Schoepke N, Asero R, Ellrich A, et al. Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: results of the PURIST study［J］. Allergy, 2019,74（12）:2427⁃2436. doi: 10.1111/all.13949.
［10］	Baioumy SA, Esawy MM, Shabana MA. Assessment of circulating FCεRIa in chronic spontaneous urticaria patients and its correlation with clinical and immunological variables［J］. Immunobiology, 2018,223（12）:807⁃811. doi: 10.1016/j.imbio. 2018.08.009.
［11］	Fagiolo U, Kricek F, Ruf C, et al. Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria［J］. J Allergy Clin Immunol, 2000,106（3）:567⁃572. doi: 10.1067/mai.2000.108913.
［12］	邹育雄, 陈明春, 谢宛潞. 慢性自发性荨麻疹患者自体血清皮肤试验与白细胞介素⁃18的关系［J］. 皮肤性病诊疗学杂志, 2020,27（3）:183⁃185. doi: 10.3969/j.issn.1674⁃8468.2020.03. 011.
［13］	Chen Q, Zhong H, Chen WC, et al. Different expression patterns of plasma Th1⁃, Th2⁃, Th17⁃ and Th22⁃related cytokines correlate with serum autoreactivity and allergen sensitivity in chronic spontaneous urticaria［J］. J Eur Acad Dermatol Venereol, 2018,32（3）:441⁃448. doi: 10.1111/jdv.14541.
［14］	de Montjoye L, Darrigade AS, Giménez⁃Arnau A, et al. Correlations between disease activity, autoimmunity and biological parameters in patients with chronic spontaneous urticaria［J］. Eur Ann Allergy Clin Immunol, 2021,53（2）:55⁃66. doi: 10.23822/EurAnnACI.1764⁃1489.132.
［15］	Kolkhir P, Church MK, Altrichter S, et al. Eosinopenia, in chronic spontaneous urticaria, is associated with high disease activity, autoimmunity, and poor response to treatment［J］. J Allergy Clin Immunol Pract, 2020,8（1）:318⁃325.e5. doi: 10. 1016/j.jaip.2019.08.025.
［16］	Grattan CE, Boon AP, Eady RA, et al. The pathology of the autologous serum skin test response in chronic urticaria resembles IgE⁃mediated late⁃phase reactions［J］. Int Arch Allergy Appl Immunol, 1990,93（2⁃3）:198⁃204. doi: 10.1159/000235301.
［17］	Curto⁃Barredo L, Yelamos J, Gimeno R, et al. Basophil activation test identifies the patients with chronic spontaneous urticaria suffering the most active disease［J］. Immun Inflamm Dis, 2016,4（4）:441⁃445. doi: 10.1002/iid3.125.
［18］	罗金成, 陈曙光, 刘文英, 等. 自体全血注射对自体血清皮肤试验阳性的难治性慢性自发性荨麻疹患者嗜碱性粒细胞FcεR Ⅰ与CD63表达的影响［J］. 中华皮肤科杂志, 2019,52（4）:241⁃247. doi: 10.3760/cma.j.issn.0412⁃4030.2019.04.004.
［19］	Curto⁃Barredo L, Pujol RM, Roura⁃Vives G, et al. Chronic urticaria phenotypes: clinical differences regarding triggers, activity, prognosis and therapeutic response［J］. Eur J Dermatol, 2019,29（6）:627⁃635. doi: 10.1684/ejd.2019.3674.
［20］	Niu XL, Zhu LL, Shi MH, et al. Association of positive and negative autologous serum skin test responses with clinical features of chronic spontaneous urticaria in Asian patients: a systematic review and meta⁃analysis［J］. Exp Ther Med, 2019,17（4）:2603⁃2613. doi: 10.3892/etm.2019.7266.
［21］	Park GH, Choi JH, Kim S, et al. The relation of autologous serum skin test and autologous plasma skin test result with various clinical and laboratory findings in patients with chronic spontaneous urticaria［J］. Ann Dermatol, 2020,32（4）:280⁃288. doi: 10.5021/ad.2020.32.4.280.
［22］	Baker R, Vasagar K, Ohameje N, et al. Basophil histamine release activity and disease severity in chronic idiopathic urticaria［J］. Ann Allergy Asthma Immunol, 2008,100（3）:244⁃249. doi: 10.1016/S1081⁃1206（10）60449⁃8.
［23］	Foti C, Romita P, Ambrogio F, et al. Analysis of clinical factors as possible predictors of response to omalizumab and relapse after treatment discontinuation in chronic spontaneous urticaria［J］. Dermatol Ther, 2021:e15248. doi: 10.1111/dth.15248.
［24］	Gericke J, Metz M, Ohanyan T, et al. Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria［J］. J Allergy Clin Immunol, 2017,139（3）:1059⁃1061.e1. doi: 10.1016/j.jaci.2016.07.047.
［25］	Chen Y, Yu M, Huang X, et al. Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both［J］. World Allergy Organ J, 2021,14（1）:100501. doi: 10.1016/j.waojou.2020.100501.
［26］	Kulthanan K, Chaweekulrat P, Komoltri C, et al. Cyclosporine for chronic spontaneous urticaria: a meta⁃analysis and systematic review［J］. J Allergy Clin Immunol Pract, 2018,6（2）:586⁃599. doi: 10.1016/j.jaip.2017.07.017.
［27］	Endo T, Toyoshima S, Kanegae K, et al. Identification of biomarkers for predicting the response to cyclosporine A therapy in patients with chronic spontaneous urticaria［J］. Allergol Int, 2019,68（2）:270⁃273. doi: 10.1016/j.alit.2018.09.006.
［28］	Yu L, Buttgereit T, Stahl Skov P, et al. Immunological effects and potential mechanisms of action of autologous serum therapy in chronic spontaneous urticaria［J］. J Eur Acad Dermatol Venereol, 2019,33（9）:1747⁃1754. doi: 10.1111/jdv.15640.

[1]	中华医学会皮肤性病学分会免疫学组. [开放获取] 中国慢性诱导性荨麻疹诊治专家共识（2023）[J]. 中华皮肤科杂志, 2023, 0(4): 20220819-e20220819.
[2]	陈奇权杨显杰顾恒徐金华郝飞姚煦宋志强. [开放获取] 基于德尔菲法构建《中国慢性诱导性荨麻疹专家诊治共识（2023）》[J]. 中华皮肤科杂志, 2023, 0(3): 20220814-e20220814.
[3]	佟馨吴剑张立明高兴华连石张海萍朱威郭在培黎静宜李萌萌何黎农祥普雄明于世荣陈洪铎肖汀. 食物特异性IgG抗体与慢性自发性荨麻疹表型的相关性研究[J]. 中华皮肤科杂志, 2023, 56(2): 130-135.
[4]	赵莹张晓艳陈璐苏玉华丁瑜洁冷红季江. 奥马珠单抗治疗难治性慢性自发性荨麻疹患者的疗效预测因子探索[J]. 中华皮肤科杂志, 2023, 56(1): 22-28.
[5]	鲁楠谭兴友刘香牛李莉姚树兰. 微RNA单核苷酸多态性与慢性自发性荨麻疹发病风险的关联分析[J]. 中华皮肤科杂志, 2022, 55(9): 806-809.
[6]	中华医学会皮肤性病学分会荨麻疹研究中心. [开放获取] 慢性荨麻疹患者宣教指南（2022）[J]. 中华皮肤科杂志, 2022, 0(4): 20220305-e20220305.
[7]	杨晓静陈雷刚王世宁吴远慧朱由瑾安国芝周向昭孟昭影. 慢性自发性荨麻疹患者血清白细胞介素9、血小板活化因子水平与总IgE、病情严重程度和病程的相关性研究[J]. 中华皮肤科杂志, 2022, 0(2): 20220235-e20220235.
[8]	中华医学会皮肤性病学分会荨麻疹研究中心. 【开放获取】中国荨麻疹诊疗指南（2022版）[J]. 中华皮肤科杂志, 2022, 55(12): 1041-1049.
[9]	高萌姜祎群. 新型冠状病毒肺炎伴发的皮肤表现[J]. 中华皮肤科杂志, 2022, 55(10): 932-934.
[10]	陈奇权杨显杰王文稳梁高澎宋志强. 胆碱能性荨麻疹临床评估工具的开发及应用进展[J]. 中华皮肤科杂志, 2022, 0(1): 20220400-e20220400.
[11]	周彤耿松梅. 生物制剂在大疱性类天疱疮治疗中的应用[J]. 中华皮肤科杂志, 2022, 0(1): 20201200-e20201200.
[12]	张宇高迎霞顾宁琰朱虹陈京京胡清洁周敏段媛媛姚煦. 奥马珠单抗对慢性自发性荨麻疹患者的临床疗效和安全性分析[J]. 中华皮肤科杂志, 2021, 54(7): 582-585.
[13]	梁高澎宋志强. 免疫球蛋白E型自身抗体在自身免疫相关皮肤病中的研究进展[J]. 中华皮肤科杂志, 2021, 54(6): 553-556.
[14]	中华医学会皮肤性病学分会荨麻疹研究中心. 抗IgE疗法——奥马珠单抗治疗慢性荨麻疹专家共识[J]. 中华皮肤科杂志, 2021, 54(12): 1057-1062.
[15]	刘鑫刘念陈宏翔. 接触性荨麻疹诊治进展[J]. 中华皮肤科杂志, 2021, 54(12): 1114-1117.

慢性自发性荨麻疹患者自体血清皮肤试验的免疫学机制及与临床特征和预后的关系

Autologous serum skin test: immunological mechanisms and its associations with clinical features and prognosis of chronic spontaneous urticaria

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 28

相关文章 15

Metrics

本文评价

推荐阅读 10